Joseph Monahan
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Joseph Monahan
The proxy statement of Aclaris Therapeutics, Inc. reports total compensation of $2,255,344 for Joseph Monahan in fiscal 2023, including a base salary of $374,400. Disclosed compensation is on record for 3 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Aclaris Therapeutics, Inc. (ACRS)
Proxy statement
Start not stated–2025-04-24
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Aclaris Therapeutics, Inc. (ACRS) | Chief Scientific Officer | $374,400 | $2,255,344 |
| 2022 | Aclaris Therapeutics, Inc. (ACRS) | Chief Scientific Officer | $420,000 | $2,822,982 |
| 2021 | Aclaris Therapeutics, Inc. (ACRS) | Chief Scientific Officer | $350,000 | $5,327,305 |
Recent activity
No call appearances or filed executive changes recorded yet.